Author(s):
R. Swetha Sri, Soundarya, K. Bhavya Sri, M. Sumakanth
Email(s):
swetha.remidicharla@gmail.com
DOI:
10.52711/2231-5675.2022.00015 
Address:
R. Swetha Sri1, Soundarya2, K. Bhavya Sri3, M. Sumakanth4
1Assistant Professor, Department of Pharmaceutical Analysis, RBVRR Women’s College of Pharmacy, Barkatpura, Hyderabad, India.
2Research Student, Department of Pharmaceutical Analysis, RBVRR Women’s College of Pharmacy, Barkatpura, Hyderabad, India.
3Head of the Department, Department of Pharmaceutical Analysis, RBVRR Women’s College of Pharmacy, Barkatpura, Hyderabad, India.
4Head of the Institution, Department of Pharmaceutical Analysis, RBVRR Women’s College of Pharmacy, Barkatpura, Hyderabad, India.
*Corresponding Author
Published In:
Volume - 12,
Issue - 2,
Year - 2022
ABSTRACT:
A Simple and precise UV-spectroscopic method was developed for the determination of Imatinib Mesylate in its bulk and formulation. The developed method has been validated for various parameters like specificity, accuracy, linearity, robustness according to USP general chapter<1225> and ICH Q2R1 guidelines. Pure solution of Imatinib Mesylate was scanned in the whole range of UV region where it has shown the maximum absorbance at 258nm. The RSD values for method precision and intermediate precision were found to be well within the acceptance criteria and the series of dilutions were found to be linear (2-12ug/ml) where r2= 0.999 was the regression value. Limit of detection (0.2925µg/ml) and Limit of quantification (0.8977µg/ml) of IMT were established. Further, the drug has been subjected to various stress conditions, and percent degraded was reported. Drug solutions have shown stability on the benchtop for up to 8 hours and 72 hours when the solutions were refrigerated.
Cite this article:
R. Swetha Sri, Soundarya, K. Bhavya Sri, M. Sumakanth. Stability Indicating UV-Spectrophotometric Method Development and its Validation for the Determination of Imatinib Mesylate in Bulk and Formulation. Asian Journal of Pharmaceutical Analysis. 2022; 12(2):83-6. doi: 10.52711/2231-5675.2022.00015
Cite(Electronic):
R. Swetha Sri, Soundarya, K. Bhavya Sri, M. Sumakanth. Stability Indicating UV-Spectrophotometric Method Development and its Validation for the Determination of Imatinib Mesylate in Bulk and Formulation. Asian Journal of Pharmaceutical Analysis. 2022; 12(2):83-6. doi: 10.52711/2231-5675.2022.00015 Available on: https://ajpaonline.com/AbstractView.aspx?PID=2022-12-2-3
REFERENCES:
1. Mahesh S. Wajurkar, Manjusha N, Dole and Sanjay D, Sawant, Development and validation of Analytical methods for estimation of imatinib mesylate in bulk and solid dosage forms by UV Spectroscopy, 2015, Vol-3(3), 214-220.
2. Suresh. D. N, Pramila. T, C, Jose Gnana Babu, Method Development and Validation of ImatinibMesylate in Bulk and Tablet Dosage Forms by Using UV- Spectrophotometric Method, 2017 Vol-3(3), 1283-1287.
3. Ms. Patilsmita J, Doijadrajendra C, Dhumalpriya P. Development of Uv-Spectrophotometric Method for the determination of Imatinib mesylate (ITM) in bulk and formulation, 2013, vol 6(3), 54-57.
4. Kumar raja. J, V.D. Sundar, AR. Magesh, S. Nandha Kumar, M.D. Dhanaraju. Validated Spectrophotometric estimation of Imatinib mesylate in pure and tablet dosage form, vol. 2(3), 490- 495.
5. Arunkumarkuna, Kunajagadeesh kumar, RP-HPLC method development and validation of Imatinib mesylate in tablet dosage form, 2011, vol 3(5), 162-165.
6. P. Ravisankar, A. Niharika, K. Anusha Rani, S. M. Neehaand G. Pavan, Development and Validation of RP-HPLC method for the quantitative determination of imatinib mesylate in bulk drug and pharmaceutical dosage form, Vol 5(7), 102-112.
7. BV Sreenivasulu and C Rambabu. New visible Spectrophotometric assay of imatinib (β-form) in pure and formulations, 2014, vol 2(1), 1-10.
8. Nalini Kanta Sahoo, Madhusmita Sahu, V Alagarsamy, B Srividya and Chinmaya KeshariSahoo, Validation of Assay Indicating Method Development of Imatinib in Bulk and Its Capsule Dosage Form by Liquid Chromatography, 2015, vol 1(2), 1-5.
9. M Akiful Haque, Vasudha Bakhshi, D Surekha, B Gouthami, C HariPriya Reddy, B Yakama, Development of UV-Spectrophotometric Method for the Determination of Imatinib Mesylate (ITM) In Bulk and Formulation, 2016, Volume 4 (2), 1130-1135
10. Reynolds JEF, Martindale- The Extra Pharmacopoeia. 28th edition, The Pharmaceutical Press, London, 1982.
11. Willard H, Merritt L, John A. Dean, and Frank A. Settle, Instrumental methods of analysis, 7th edition, CBS Publishers and Distributors, New Delhi, 1986.
12. ICH Guidance for Industry, Q1B Photostbilitytestings of new drug substance and product, International Conference on Harmonization. Compliance Regulatory Information/ Guidances.pdf (1996).
13. G Boccradi – oxidative susceptibility, testing in S.W. Baertschi (Ed.), Pharmaceutical stress Testing predicting Drug Degradation, Taylor and Francis, new york, 2005;220
14. M. Allwood, J. The plane, the wavelength-dependent degradation of vitamin A exposed to ultraviolet radiation, Int. J. Pharm, 1986; 31:1-7.